Skip to main content

Caxton Associates LP

SEC CIK
0000872573
Latest filing
Feb 14, 2025

ITCI holding history

Intra-Cellular Therapies, Inc. in every 13F filed by Caxton Associates LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ITCI overviewAll 13F holders of ITCIFull Q4 2024 holdings

Shares (Q2 2022)
0
Sold out in Q2 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q1 2022
Holdings of ITCI by Caxton Associates LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20220$00.0%−14,591−100.0%Sold outHolders
Q1 202214,591$893.0K0.1%+14,591NewHolders